Abstract
AB021. Histopathologic characteristics of resected thymic cyst walls, with imaging correlation
Mediastinum
2021;
5:
AB021
(30 December 2021)
Abstract
AB020. Syndrome coronavirus type 2 (SARS-CoV-2) infection in patient with thymoma: presentation of two cases
Mediastinum
2021;
5:
AB020
(30 December 2021)
Abstract
AB019. Extended subxiphoid thymectomy for a large B3/B2 thymoma with positive acetylcholine receptor antibodies but without myasthenia
Mediastinum
2021;
5:
AB019
(30 December 2021)
Abstract
AB018. Advances in mediastinal tumors diagnosis: J. Rosai, a master of Pathology, and the value of morphology and related disciplines
Mediastinum
2021;
5:
AB018
(30 December 2021)
Abstract
AB017. Oncological outcomes of robotic extended thymectomy for early stage thymoma compared to sternotomy: a retrospective single centre institution analysis
Mediastinum
2021;
5:
AB017
(30 December 2021)
Abstract
AB016. Different pattern of indoleamine 2,3-dioxygenase 1 (IDO1) and PD-L1 immunoexpression in thymomas
Mediastinum
2021;
5:
AB016
(30 December 2021)
Abstract
AB015. Importance of an international refining of histopathological criteria of pT in thymic epithelial tumors: a RYTHMIC/ITMIG study
Mediastinum
2021;
5:
AB015
(30 December 2021)
Abstract
AB014. A case of Li-Fraumeni syndrome associated thymoma
Mediastinum
2021;
5:
AB014
(30 December 2021)
Abstract
AB013. Tolerability of COVID-19 mRNA vaccines in patients with thymic epithelial tumors
Mediastinum
2021;
5:
AB013
(30 December 2021)
Abstract
AB012. Transcriptional and chromatin profiling reveals the molecular architecture and druggable vulnerabilities of thymic epithelial tumors (TETs)
Mediastinum
2021;
5:
AB012
(30 December 2021)
Abstract
AB011. Rescue chemotherapy in a patient with thymoma and severe symptoms of myasthenia gravis: a case report
Mediastinum
2021;
5:
AB011
(30 December 2021)
Abstract
AB010. Incidental discovery of thymic masses during syndrome coronavirus type 2 (SARS-CoV-2) infection
Mediastinum
2021;
5:
AB010
(30 December 2021)
Abstract
AB009. Pitfalls in mediastinal masses diagnosis
Mediastinum
2021;
5:
AB009
(30 December 2021)
Abstract
AB008. Synchronous thymic and breast malignancies: a single institutional experience
Mediastinum
2021;
5:
AB008
(30 December 2021)
Abstract
AB007. Preliminary data of immunogenicity of SARS-COV-2 mRNA vaccine in thymic epithelial tumors
Mediastinum
2021;
5:
AB007
(30 December 2021)
Abstract
AB006. Molecular profiling of genetic alterations in thymic epithelial tumors by targeted next generation sequencing: a pilot study
Mediastinum
2021;
5:
AB006
(30 December 2021)
Abstract
AB005. Post operative management and outcome of high risk thymoma and thymic carcinoma following curative intent surgery: a single centre experience
Mediastinum
2021;
5:
AB005
(30 December 2021)
Abstract
AB004. Optimal delineation of the clinical target volume for thymomas in the postoperative setting: a multi-center study
Mediastinum
2021;
5:
AB004
(30 December 2021)
Abstract
AB003. Circulating EBV (cEBV) and metabolic imaging monitoring during therapy for thymic lymphoepithelioma-like carcinoma (tLELC): a case study
Mediastinum
2021;
5:
AB003
(30 December 2021)
Abstract
AB002. Robotic thymectomy for thymomas: a retrospective follow-up study in The Netherlands
Mediastinum
2021;
5:
AB002
(30 December 2021)
Abstract
AB001. Subclinical myasthenia gravis in thymomas
Mediastinum
2021;
5:
AB001
(30 December 2021)
Disclosure:
The “Abstract Book for the 11th International Thymic Malignancy Interest Group Annual Meeting (Virtual ITMIG 2021)” was commissioned by the editorial office, Mediastinum without any sponsorship or funding.